JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 17, 2004; DOI: 10.1124/jpet.104.073437


0022-3565/05/3121-256-264$20.00
JPET 312:256-264, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.073437v1
312/1/256    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pulfer, M. K.
Right arrow Articles by Murphy, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pulfer, M. K.
Right arrow Articles by Murphy, R. C.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Ozone Exposure in Vivo and Formation of Biologically Active Oxysterols in the Lung

Melissa K. Pulfer, Christian Taube, Erwin Gelfand, and Robert C. Murphy

Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado (M.K.P., C.T., E.G., R.C.M.); and Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, Colorado (M.K.P., R.C.M.)

Ozone toxicity in the lung is thought to be mediated by products derived from the reaction of ozone with components of the lung epithelial lining fluid. Cholesterol is an abundant component of this epithelial lining fluid, and it is susceptible to ozonolysis, yielding several stable products including 3{beta}-hydroxy-5-oxo-5,6-secocholestan-6-al and 5{beta},6{beta}-epoxycholesterol. Both 5{beta},6{beta}-epoxycholesterol and its metabolite, cholestan-6-oxo-3,5-diol, have been shown to cause cytotoxicity in vitro, suggesting that they may be potential mediators of ozone toxicity in vivo. An ozone-sensitive mouse strain, C57BL/6J, was exposed to varying concentrations of ozone (0.5-3.0 ppm), and subsequently the levels of these cholesterol ozonolysis products were quantitated by electrospray ionization mass spectrometry in bronchoalveolar lavage fluid, lavaged cells, and lung homogenate. An ozone dose-dependent formation of these biologically active oxysterols was observed in vivo, supporting a role for these compounds in ozone toxicity. Since the 5{beta},6{beta}-epoxycholesterol metabolite, cholestan-6-oxo-3,5-diol, was isobaric with other cholesterol ozonolysis products, 3{beta}-hydroxy-5-oxo-5,6-secocholestan-6-al and its aldol condensation product, 3{beta}-hydroxy-5{beta}-hydroxy-B-norcholestan-6{beta}-carboxaldehyde, detailed mass spectral analysis using electron impact ionization was utilized to differentiate these isobaric cholesterol ozonolysis products. The specific detection of cholestan-6-oxo-3,5-diol in lung homogenate after ozone exposure established formation of 5{beta},6{beta}-epoxycholesterol within the lung after exposure to 0.5 ppm ozone.


Received June 28, 2004; accepted August 17, 2004.

Address correspondence to: Dr. Robert C. Murphy, Department of Pharmacology, University of Colorado Health Sciences Center, Mail Stop 8303, P.O. Box 6508, Aurora, CO 80045-0508. E-mail: robert.murphy{at}uchsc.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. C. Murphy and K. M. Johnson
Cholesterol, Reactive Oxygen Species, and the Formation of Biologically Active Mediators
J. Biol. Chem., June 6, 2008; 283(23): 15521 - 15525.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yang, J. G. McDonald, A. Patel, Y. Zhang, M. Umetani, F. Xu, E. J. Westover, D. F. Covey, D. J. Mangelsdorf, J. C. Cohen, et al.
Sterol Intermediates from Cholesterol Biosynthetic Pathway as Liver X Receptor Ligands
J. Biol. Chem., September 22, 2006; 281(38): 27816 - 27826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Manzer, J. Wang, K. Nishina, G. McConville, and R. J. Mason
Alveolar Epithelial Cells Secrete Chemokines in Response to IL-1beta and Lipopolysaccharide but Not to Ozone
Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 158 - 166.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.